InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Browse the detailed record of transactions filed by Goeltz II Robert C., Chief Financial Officer. Director active across 1 companies, notably Arcus Biosciences, Inc.. In total, 7 reports have been recorded. Total volume traded: €534k. The latest transaction was disclosed on 11 May 2026 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations7 total
US$168,9027,763 shares@ US$21.75730.0056% mcap63.2% of flow
Common Stock
SEC:0001653881-26-000005·
€168,9027,763 shares@ €21.75730.0056% mcap31.6% of flow
Common Stock
SEC:0001653881-26-000005:0·
US$85,8245,000 shares@ US$17.16480.0029% mcap32.1% of flow
Common Stock
SEC:0001653881-25-000005·
€85,8245,000 shares@ €17.16480.0029% mcap16.1% of flow
Common Stock
SEC:0001653881-25-000005:0·
015,500 shares0
Common Stock
SEC:0001209191-22-017984:0·
€12,413354 shares@ €35.06550.0004% mcap4.6% of flow
Common Stock
SEC:0001209191-21-070565·
€12,413354 shares@ €35.06550.0004% mcap2.3% of flow
Common Stock
SEC:0001209191-21-070565:0·
7 of 7 declarations
About Goeltz II Robert C.
Robert C. Goeltz II is the Chief Financial Officer at Arcus Biosciences, Inc. He is responsible for financial management and strategy for the company. His financial expertise is essential for supporting Arcus's growth and sustainability.